Study to Evaluate Safety and Immunologic Biomarker of Rapamune in Patients With Stable Renal Transplant Recipient
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
For patients who meet the inclusion criteria and who agree to participate in this study, the
investigators sampled peripheral blood 10cc and performed the analysis for immunologic
profile just before the conversion of immune suppressant. At 1 month, 6 month, and 1 year
from the conversion of Immune suppressant (CNI to rapamune), the investigators performed tha
analysis fo immune profile again. During the study period, the interval of the visit of
subclinic and the kinds of laboratory test (Blood and urine test) would not change compared
to before the start of this study.